car t-cell therapy death rate：Nonrelapse mortality after CAR T
Nonrelapse mortality after CAR T
由JLemoine著作·2023·被引用11次—TheNRMrateestimateafterCART-celltherapyforlargeB-celllymphomaswas5%,with∼80%ofdeathsoccurringbeyondday28afterinfusion.·Infectionsare ...。其他文章還包含有：「ACureforCancer?HowCAR」、「ComorbiditiesAssociatedwithEarlyMortalityafterCD19CAR...」、「Evaluationofall」、「ImpactofIncreasingWaitTimesonOverallMortality...」、「InfectionMainCauseofNonrelapseDeathsWithCAR...
查看更多 離開網站
A Cure for Cancer? How CAR
https://www.labiotech.eu
According to the study, the death rate for both therapies was 5.4%. As a comparison, that of immune checkpoint therapy lies between 0.36% and ...
Comorbidities Associated with Early Mortality after CD19 CAR ...
https://ashpublications.org
Early 30-day mortality occurred in 4.8% pts and causes of death due to CAR-T related toxicity in 6 pts, disease progression in 3 pts, and ...
Evaluation of all
https://www.thelancet.com
Chimeric antigen receptor T cell (CAR T) therapy has been shown to be effective in the treatment of selected B cell malignancies. Six CAR T cell ...
Impact of Increasing Wait Times on Overall Mortality ...
https://pubmed.ncbi.nlm.nih.go
Results: Increasing the wait time of receiving CAR T-cell therapy from 1 to 9 months increased the predicted 1-year mortality rate from 36.1% to 76.3%. Baseline ...
Infection Main Cause of Nonrelapse Deaths With CAR T
https://www.medscape.com
The overall point estimate of nonrelapse mortality among all patients was 7.6% at a median follow-up of 13.2 months. The point estimates were ...
Infections cause 'high' rate of nonrelapse deaths among ...
https://www.healio.com
Investigators calculated a nonrelapse mortality of 7.6% among CAR-T recipients at median follow-up of 13.2 months. Infections accounted for ...
Long
https://www.nature.com
This study demonstrated a CR rate of 55%, and 60% of these patients remained in remission at 5 years. Overall, these results demonstrate that ...
Nonrelapse mortality after CAR T
https://ashpublications.org